Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Urinary Incontinence 1Nocturnal Enuresis 1Neoplasms 1Diurnal Enuresis 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × mebeverine × Clear all
NCT04635566 2020-11-19

Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute

Mansoura University

Phase NA Completed
120 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Incontinence

NCT03147599 2020-06-30

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Mansoura University

Phase 4 Completed
110 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms, Nocturnal Enuresis, Diurnal Enuresis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡